Morgan Stanley values BCI market at $400 billion by 2040 in landmark research report
Summary
Morgan Stanley published a major equity research report valuing the brain-computer interface market at $400 billion by 2040, citing Neuralink, Synchron, Precision Neuroscience, and Paradromics as leading players across implantable BCI, and Meta, Neurable, and Samsung as leaders in non-invasive neural interfaces. The report projected initial BCI revenues will come from communication assistive devices for paralysis starting 2027-2028, expanding to cognitive enhancement and consumer applications by 2035.
Why it matters
A $400B market projection from the world's largest investment bank carries enormous weight with institutional investors who have been cautious about neurotech. Morgan Stanley's coverage legitimizes BCI as a mainstream investment category and will drive significant new capital into both public and private neurotech companies.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial